^Bhardwaj, R. K.; Glaeser, H.; Becquemont, L.; Klotz, U.; Gupta, S. K.; Fromm, M. F. "Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4." J. Pharmacol. Exp. Ther.2002, 302, 645-650.
^Atal, C. K.; Dubey, R. K.; Singh, J. "Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism." J. Pharmacol. Exp. Ther.1985, 232, 258-262.
^Reen, R. K.; Jamwal, D. S.; Taneja, S. C.; Koul, J. L.; Dubey, R. K.; Wiebel, F. J.; Singh, J. "Impairment of UDP-glucose dehydrogenase and glucuronidation activities in liver and small intestine of rat and guinea pig in vitro by piperine." Biochem. Pharmacol.1993, 46, 229-238.
^Shoba, G.; Joy, D.; Joseph, T.; Majeed, M.; Rajendran, R.; Srinivas, P. S. "Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers." Planta Med.1998, 64, 353-356.